Ancilia Bio harnesses CRISPR and proprietary platforms to develop beneficial bacterial products with immunity against destructive viruses, including live biotherapeutics and other bacterial products.
Ancilia Bio harnesses CRISPR and proprietary platforms to develop beneficial bacterial products with immunity against destructive viruses, including live biotherapeutics and other bacterial products.